Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% is a generic version of Alcon Pharmaceuticals’ Vigamox, an antibiotic solution that is indicated for the treatment of bacterial conjunctivitis. Alcon Pharmaceuticals
Amgen has also agreed to reacquire rights in Brazil to its products that were previously granted to Mantecorp (subsequently acquired by Hypermarcas). Amgen has entered into an agreement
The CVR entitles Sanofi-aventis to receive additional cash payments if specified milestones related to Lemtrada (alemtuzumab MS) are achieved over time or a milestone related to production volumes
The latest TEKLYNX innovation enables auditable tracking of user activity across TEKLYNX’ proven label design, printing, security and tracing applications. In addition to security measures, TEKLYNX CENTRAL CFR
Once the acquisition is completed, SOHM expects to add 17 new product offerings. SOHM president and CEO Shailesh Shah said they not only gain new products to further
The new machine is fully automated and capable of filling and over-encapsulating a wide range of solid and liquid products. At present it has filling stations for powders,
The Divalproex Sodium delayed release tablets USP 125mg, 250mg and 500mg (Valproic Acid Activity) are therapeutically equivalent to Abbott Laboratories’ Depakote delayed-release tablets USP 125mg, 250mg, and 500mg.
The composition may be used alone or as an adjuvant with a pox antigen-based vaccine, especially in the treatment or prophylaxis of viral infections such as smallpox. TapImmune
Under the agreement, compounds will be developed using Zacharon’s platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans. As per the terms of the agreement,
The products include Kang Xi Eye Patch, KangXi Dental Ulcer Membrane, KangXi Anti-virus Mouthwash, KangXi Dental Ulcer Mouthwash, KangXi Snore Stopper, Kang Xi Periarthritis Shoulder Patch, KangXi Cervical
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.